Mobile

A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004380-58

A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS)

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• A pilot study to assess the urodynamic changes induced by 100mg MR formulation of UK-369,003 vs. placebo in men with LUTS. • Assess the safety and tolerability of UK-369,003 in men with LUTS

Critère d'inclusion

  • Lower urinary tract symptoms

Liens